These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24792688)

  • 1. Is tissue harmonic ultrasound imaging (THI) of the prostatic urethra and rectum superior to brightness (B) mode imaging? An observer study.
    Sandhu GK; Angyalfi S; Dunscombe PB; Khan RF
    Phys Med; 2014 Sep; 30(6):662-8. PubMed ID: 24792688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter- and intra-observer variability in prostate definition with tissue harmonic and brightness mode imaging.
    Sandhu GK; Dunscombe P; Meyer T; Pavamani S; Khan R
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e9-16. PubMed ID: 21489703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poster - Thur Eve - 12: Dosimetric manifestation of harmonic mode imaging for seed implant brachytherapy.
    Sandhu G; Angyalfi S; Dunscombe P; Khan R
    Med Phys; 2012 Jul; 39(7Part2):4626. PubMed ID: 28516544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pre-clinical phantom comparison of tissue harmonic and brightness mode imaging for application in ultrasound guided prostate brachytherapy.
    Sandhu GK; Dunscombe PB; Khan RF
    Phys Med; 2011 Jul; 27(3):153-62. PubMed ID: 21035371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rectum dose reduction and individual treatment plan optimization for high-dose-rate prostate brachytherapy.
    Bölling T; Moustakis C; Elsayed H; Müller SB; Weining C; Reinartz G; Ernst I; Willich N; Könemann S
    Brachytherapy; 2007; 6(4):280-5. PubMed ID: 17991624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of brachytherapy seeds using 3-D transrectal ultrasound.
    Wen X; Salcudean ST; Lawrence PD
    IEEE Trans Biomed Eng; 2010 Oct; 57(10):2467-77. PubMed ID: 20595088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of interobserver variability on transrectal ultrasonography-based postimplant dosimetry.
    Xue J; Waterman F; Handler J; Gressen E
    Brachytherapy; 2006; 5(3):174-82. PubMed ID: 16864069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of intraoperative ultrasound with postimplant computed tomography--dosimetric values at Day 1 and Day 30 after prostate brachytherapy.
    Ohashi T; Yorozu A; Toya K; Saito S; Momma T; Nagata H; Kosugi M; Shigematsu N; Kubo A
    Brachytherapy; 2007; 6(4):246-53. PubMed ID: 17959425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shape analysis of the prostate: establishing imaging specifications for the design of a transurethral imaging device for prostate brachytherapy guidance.
    Holmes DR; Davis BJ; Goulet CC; Wilson TM; Mynderse LA; Furutani KM; Camp JJ; Robb RA
    Brachytherapy; 2014; 13(5):465-70. PubMed ID: 24962657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate brachytherapy with oblique needles to treat large glands and overcome pubic arch interference.
    Ryu B; Bax J; Edirisinge C; Lewis C; Chen J; D'Souza D; Fenster A; Wong E
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1463-72. PubMed ID: 22270172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
    Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric impact of interfraction catheter movement in high-dose rate prostate brachytherapy.
    Foster W; Cunha JA; Hsu IC; Weinberg V; Krishnamurthy D; Pouliot J
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):85-90. PubMed ID: 20605353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging of implant needles for real-time HDR-brachytherapy prostate treatment using biplane ultrasound transducers.
    Siebert FA; Hirt M; Niehoff P; Kovács G
    Med Phys; 2009 Aug; 36(8):3406-12. PubMed ID: 19746773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity modulated brachytherapy or EBRT for prostate cancer patients.
    Prada PJ; Fernández J; Martinez AA; de la Rúa A; Gonzalez JM; Fernandez JM; Juan G
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):95-102. PubMed ID: 17707267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of CBCT-based target and normal structure delineation in prostate cancer radiotherapy: multi-observer and image multi-modality study.
    Lütgendorf-Caucig C; Fotina I; Stock M; Pötter R; Goldner G; Georg D
    Radiother Oncol; 2011 Feb; 98(2):154-61. PubMed ID: 21176984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical discussion of different dose-volume parameters for rectum and urethra in prostate brachytherapy.
    Kirisits C; Goldner G; Berger D; Georg D; Pötter R
    Brachytherapy; 2009; 8(4):353-60. PubMed ID: 19446499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of prostate volume, shape, and contouring variability determined from preimplant magnetic resonance and transrectal ultrasound images.
    Liu D; Usmani N; Ghosh S; Kamal W; Pedersen J; Pervez N; Yee D; Danielson B; Murtha A; Amanie J; Sloboda RS
    Brachytherapy; 2012; 11(4):284-91. PubMed ID: 22197014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of prostatic volume with transrectal ultrasound: A study of intra-observer and interobserver variation.
    Bates TS; Reynard JM; Peters TJ; Gingell JC
    J Urol; 1996 Apr; 155(4):1299-300. PubMed ID: 8632559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformal prostate brachytherapy: initial experience of a phase I/II dose-escalating trial.
    Martinez A; Gonzalez J; Stromberg J; Edmundson G; Plunkett M; Gustafson G; Brown D; Yan D; Vicini F; Brabbins D
    Int J Radiat Oncol Biol Phys; 1995 Dec; 33(5):1019-27. PubMed ID: 7493828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk.
    Crook JM; Potters L; Stock RG; Zelefsky MJ
    Brachytherapy; 2005; 4(3):186-94. PubMed ID: 16182218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.